Albert Labs Announces a Distinguished Clinical and Scientific Advisory Board

Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief...

Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has...

Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production...

Silo Wellness Debuts Marley One, the First Global Functional and Psychedelic...

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic...

Book Review: Alexander Shulgin’s The Nature of Drugs

Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board

MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer’s disease and...

Load more